Low risk of ICH after reperfusion therapy in acute stroke patients treated with direct oral anti-coagulant

Risk of ICH after reperfusion therapy in patients treated with DOAC should be low. Systolic blood pressure, glucose level, and DOAC intake time appear to be factors for ICH.